BioSyent Statistics

Total Valuation

BioSyent has a market cap or net worth of CAD 132.80 million. The enterprise value is 116.39 million.

Market Cap	132.80M
Enterprise Value	116.39M

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	May 30, 2025

Share Statistics

BioSyent has 11.25 million shares outstanding. The number of shares has decreased by -2.77% in one year.

Current Share Class	11.25M
Shares Outstanding	11.25M
Shares Change (YoY)	-2.77%
Shares Change (QoQ)	-1.69%
Owned by Insiders (%)	14.14%
Owned by Institutions (%)	19.22%
Float	8.58M

Valuation Ratios

The trailing PE ratio is 17.68 and the forward PE ratio is 15.18.

PE Ratio	17.68
Forward PE	15.18
PS Ratio	3.47
PB Ratio	3.69
P/TBV Ratio	4.26
P/FCF Ratio	19.14
P/OCF Ratio	19.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.88, with an EV/FCF ratio of 16.77.

EV / Earnings	14.88
EV / Sales	3.04
EV / EBITDA	10.88
EV / EBIT	11.54
EV / FCF	16.77

Financial Position

The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.03.

Current Ratio	4.90
Quick Ratio	3.90
Debt / Equity	0.03
Debt / EBITDA	0.09
Debt / FCF	0.14
Interest Coverage	177.97

Financial Efficiency

Return on equity (ROE) is 22.17% and return on invested capital (ROIC) is 17.33%.

Return on Equity (ROE)	22.17%
Return on Assets (ROA)	15.23%
Return on Invested Capital (ROIC)	17.33%
Return on Capital Employed (ROCE)	27.32%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.93
Inventory Turnover	1.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.61% in the last 52 weeks. The beta is 0.44, so BioSyent's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+26.61%
50-Day Moving Average	10.94
200-Day Moving Average	11.02
Relative Strength Index (RSI)	64.26
Average Volume (20 Days)	6,018

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSyent had revenue of CAD 38.28 million and earned 7.82 million in profits. Earnings per share was 0.67.

Revenue	38.28M
Gross Profit	30.05M
Operating Income	10.08M
Pretax Income	10.53M
Net Income	7.82M
EBITDA	10.56M
EBIT	10.08M
Earnings Per Share (EPS)	0.67

Full Income Statement

Balance Sheet

The company has 17.40 million in cash and 990,218 in debt, giving a net cash position of 16.41 million or 1.46 per share.

Cash & Cash Equivalents	17.40M
Total Debt	990,218
Net Cash	16.41M
Net Cash Per Share	1.46
Equity (Book Value)	36.01M
Book Value Per Share	3.20
Working Capital	22.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.99 million and capital expenditures -49,457, giving a free cash flow of 6.94 million.

Operating Cash Flow	6.99M
Capital Expenditures	-49,457
Free Cash Flow	6.94M
FCF Per Share	0.62

Full Cash Flow Statement

Margins

Gross margin is 78.51%, with operating and profit margins of 26.35% and 20.43%.

Gross Margin	78.51%
Operating Margin	26.35%
Pretax Margin	27.52%
Profit Margin	20.43%
EBITDA Margin	27.59%
EBIT Margin	26.35%
FCF Margin	18.13%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.70%.

Dividend Per Share	0.20
Dividend Yield	1.70%
Dividend Growth (YoY)	11.76%
Years of Dividend Growth	3
Payout Ratio	27.09%
Buyback Yield	2.77%
Shareholder Yield	4.47%
Earnings Yield	5.89%
FCF Yield	5.23%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioSyent has an Altman Z-Score of 13.94.

Altman Z-Score	13.94
Piotroski F-Score	n/a